BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24770497)

  • 1. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis.
    Bragança GM; Lima SO; Pinto Neto AF; Marques LM; Melo EV; Reis FP
    An Bras Dermatol; 2014; 89(2):230-5. PubMed ID: 24770497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH).
    Bahar R; Zhou P; Liu Y; Huang Y; Phillips A; Lee TK; Su M; Yang S; Kalia S; Zhang X; Zhou Y
    J Am Acad Dermatol; 2016 Dec; 75(6):1126-1133. PubMed ID: 27567033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between preoperative psychological evaluation and compensatory sweating.
    Wang HY; Zhu YJ; Liu J; Li LW; Liu YH
    J Cardiothorac Surg; 2018 May; 13(1):42. PubMed ID: 29776420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro.
    Ribeiro Santos Morard M; Betanho Martins R; Lopes Ribeiro AC; Guimarães Rocha Lima P; Dos Santos Carvalho B; Junior JCBS
    PLoS One; 2019; 14(9):e0220664. PubMed ID: 31518360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Characteristics of Hyperhidrosis in Sweden: A Cross-Sectional Study in the General Population.
    Shayesteh A; Janlert U; Brulin C; Boman J; Nylander E
    Dermatology; 2016; 232(5):586-591. PubMed ID: 27576462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil.
    Lima SO; Aragão JF; Machado Neto J; Almeida KB; Menezes LM; Santana VR
    An Bras Dermatol; 2015; 90(5):661-5. PubMed ID: 26560211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhidrosis - Sweating Sites Matter: Quality of Life in Primary Hyperhidrosis according to the Sweating Sites Measured by SF-36.
    Shayesteh A; Janlert U; Nylander E
    Dermatology; 2017; 233(6):441-445. PubMed ID: 29502112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of depression and anxiety in patients with chronic digestive system diseases: A multicenter epidemiological study.
    Zhang AZ; Wang QC; Huang KM; Huang JG; Zhou CH; Sun FQ; Wang SW; Wu FT
    World J Gastroenterol; 2016 Nov; 22(42):9437-9444. PubMed ID: 27895432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients.
    Walling HW
    J Am Acad Dermatol; 2009 Aug; 61(2):242-6. PubMed ID: 19395123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperhidrosis: Implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin.
    Shayesteh A; Boman J; Janlert U; Brulin C; Nylander E
    J Dermatol; 2016 Aug; 43(8):928-33. PubMed ID: 26875781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary hyperhidrosis and anxiety: a prospective preoperative survey of 158 patients].
    Ramos R; Moya J; Turón V; Pérez J; Villalonga R; Morera R; Perna V; Ferrer G
    Arch Bronconeumol; 2005 Feb; 41(2):88-92. PubMed ID: 15718003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
    J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic analysis of prevalence of the hyperhidrosis.
    Estevan FA; Wolosker MB; Wolosker N; Puech-Leão P
    An Bras Dermatol; 2017; 92(5):630-634. PubMed ID: 29166497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis.
    Fujimoto T; Kawahara K; Yokozeki H
    J Dermatol; 2013 Nov; 40(11):886-90. PubMed ID: 24106874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.
    Pinto-Sanchez MI; Ford AC; Avila CA; Verdu EF; Collins SM; Morgan D; Moayyedi P; Bercik P
    Am J Gastroenterol; 2015 Jul; 110(7):1038-48. PubMed ID: 25964226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety after Sympathectomy in patients with primary palmar hyperhidrosis may prolong the duration of compensatory hyperhidrosis.
    Qian K; Feng YG; Zhou JH; Wang RW; Tan QY; Deng B
    J Cardiothorac Surg; 2018 Jun; 13(1):54. PubMed ID: 29859106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First- and last-year medical students: is there a difference in the prevalence and intensity of anxiety and depressive symptoms?
    Bassols AM; Okabayashi LS; Silva AB; Carneiro BB; Feijó F; Guimarães GC; Cortes GN; Rohde LA; Eizirik CL
    Braz J Psychiatry; 2014 Sep; 36(3):233-40. PubMed ID: 24676042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the serum magnesium and vitamin D levels and the risk of anxiety in primary hyperhidrosis.
    Manav V; Türk CB; Kara Polat A; Erdil D; Baş S; Koku Aksu AE
    J Cosmet Dermatol; 2022 Jan; 21(1):373-379. PubMed ID: 33738914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Anxiety and Depression With Pain and Quality of Life in Patients With Chronic Foot and Ankle Diseases.
    Nakagawa R; Yamaguchi S; Kimura S; Sadamasu A; Yamamoto Y; Sato Y; Akagi R; Sasho T; Ohtori S
    Foot Ankle Int; 2017 Nov; 38(11):1192-1198. PubMed ID: 28814108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis.
    Cai Q; Teeple A; Wu B; Muser E
    J Med Econ; 2019 Dec; 22(12):1290-1297. PubMed ID: 31262226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.